Healthy Aging in Asia: Assessing the Net Value of Chronic Disease Management
Improvements in medical treatment have clearly contributed to significant increases in medical spending, yet there is relatively little quantitative evidence on whether the rise in expenditure is “worth it” in the sense of producing health outcomes of commensurate value. This seminar will focus on empirical research assessing the net value of health care for patients with chronic disease, using the case of type 2 diabetes mellitus. Based on analysis of detailed longitudinal, patient-level data, the collaborating researchers from Hong Kong, Japan, Taiwan, the Netherlands, and the US describe patterns in resource use and quality outcomes as measured by clinical markers and predicted risk of complications and death. In most of the studied cases, increases in spending were accompanied with improvements in outcomes of commensurate or greater value, given a range of values for a quality-adjusted life year. The authors conclude with a discussion of what the results imply about productivity of medical care, quality adjustment of price indices for healthcare, and policies for healthy aging in Asia (based on a forthcoming book).
Toshiaki Iizuka
Toshiaki Iizuka is Professor at Graduate School of Public Policy and Graduate School of Economics, the University of Tokyo. Before joining the University of Tokyo in 2010, he taught at Vanderbilt University (2001-2005), Aoyama Gakuin University (2005-2009), and Keio University (2009-2010). He served as Dean of Graduate School of Public Policy, the University of Tokyo, between 2016 and 2018. He is a recipient of Abe Fellowship (2018-2019).
His research interests are in the field of health economics and health policy. He has written a number of articles on incentive and information in the health care markets. His research articles have appeared in leading professional journals, including American Economic Review, RAND Journal of Economics, Journal of Health Economics, and Health Affairs, among others. Dr. Iizuka holds a PhD in Economics from the University of California, Los Angeles, an MIA from Columbia University, and an ME and BE from the University of Tokyo.
Karen Eggleston
Shorenstein APARC
Stanford University
Encina Hall E301
Stanford, CA 94305-6055
Karen Eggleston is a Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University and Director of the Stanford Asia Health Policy Program at the Shorenstein Asia-Pacific Research Center at FSI. She is also a Fellow with the Center for Innovation in Global Health at Stanford University School of Medicine, and a Faculty Research Fellow of the National Bureau of Economic Research (NBER). Her research focuses on government and market roles in the health sector and Asia health policy, especially in China, India, Japan, and Korea; healthcare productivity; and the economics of the demographic transition.
Eggleston earned her PhD in public policy from Harvard University and has MA degrees in economics and Asian studies from the University of Hawaii and a BA in Asian studies summa cum laude (valedictorian) from Dartmouth College. Eggleston studied in China for two years and was a Fulbright scholar in Korea. She served on the Strategic Technical Advisory Committee for the Asia Pacific Observatory on Health Systems and Policies and has been a consultant to the World Bank, the Asian Development Bank, and the WHO regarding health system reforms in the PRC.
FSI scholars approach their research on the environment from regulatory, economic and societal angles. The Center on Food Security and the Environment weighs the connection between climate change and agriculture; the impact of biofuel expansion on land and food supply; how to increase crop yields without expanding agricultural lands; and the trends in aquaculture. FSE’s research spans the globe – from the potential of smallholder irrigation to reduce hunger and improve development in sub-Saharan Africa to the devastation of drought on Iowa farms.